Chugai Commits $220M Into Singapore Drug Lab Post author:Sam Post published:December 28, 2017 Post category:BioPharma The drugmaker intends to expand development of therapeutic antibodies at the lab. Source: BioSpace You Might Also Like Nemaura Medical Reports First Quarter 2017 Financial Results August 9, 2017 U.S. Asset Manager Wants in On China Biotech Unicorn Innovent Biologics' $200M+ IPO January 14, 2018 Alder BioPharmaceuticals Announces Closing of $250M of 2.50% Convertible Senior Notes Due 2025 February 1, 2018
Alder BioPharmaceuticals Announces Closing of $250M of 2.50% Convertible Senior Notes Due 2025 February 1, 2018
